Diabetes Articles
  • Sign Up
FacebookTwitterDiggStumbleuponGoogle BookmarksRedditLinkedinPinterest

New Type of Diabetes Drug Drops Weight With Blood Sugar

SGLT2 Inhibitors Boost Metformin, Can Be Used Even in Late-Stage Diabetes

By Daniel J. DeNoon
from WebMD
Now the first of these so-called SGLT2 inhibitors has been tested in a phase III clinical trial. It's dapagliflozin, being jointly developed by Bristol-Myers Squibb and AstraZeneca.

Study leader Clifford J. Bailey, PhD, is professor of clinical science at Aston University in Birmingham, England. "It works through an entirely different mechanism than any other diabetes drugs currently available," Bailey tells WebMD. "And you can add it on to other treatments and get an additional benefit. Plus as far as we can see, it can be used at any stage in the disease process."

And that's not all. Because dapagliflozin makes the body excrete excess sugar, it makes diabetes patients lose weight. Metformin helps patients lose weight, too, but those adding dapagliflozin to metformin lost about 4 and 1/2 more pounds than those taking metformin alone in the 24-week study.

The lost weight was not just water. Patients taking dapagliflozin had smaller waistlines, so the lost weight appears to have been fat.

Might this new diabetes drug work as a weight loss pill? No, says Bailey.

"The weight loss effect of the drug becomes less and less as the blood-sugar level comes to near normal," he notes. "Therefore the weight loss potential of this drug is very small at normal blood-sugar levels."

Weight loss isn't dapagliflozin's only extra benefit. It lowers blood pressure, too. Another plus is that the oral medication is taken only once a day. And the drug does not lower blood sugar to dangerously low levels -- yet another plus.

On the down side, patients taking dapagliflozin had an increased risk of genital infections. People with diabetes already are at higher risk of genital and urinary infections. Dapagliflozin may increase this risk.

And because the drug changes the way the body excretes fluid, there may be as-yet-unseen long-term consequences, suggests Luigi F. Meneghini, MD, MBA, director of the University of Miami's diabetes treatment center. Meneghini was not involved in the Bailey study.

"If you have more sugar in your urinary tract, you have more risk of infection. This probably has to do with people with diabetes and high blood sugar having more fungal infections," Meneghini tells WebMD. "That said, if your doctor is careful in monitoring for you infections and treating them when they occur, this is still a drug with a relatively low side-effect profile. But we need to see data on lots more people exposed to the drug for a longer time."

The Bailey study enrolled patients whose blood sugar was not adequately controlled by metformin alone. Their blood sugar was too high but not wildly out of control.

Sources include:
http://diabetes.webmd.com/news/20100625/new-type-diabetes-drug-drops-weight-with-blood-sugar
http://www1.aston.ac.uk/lhs/staff/az-index/baileycj/
http://dddmag.com/news-Dapagliflozin-Achieves-Reductions-in-A1c-Levels-62310.aspx
http://en.wikipedia.org/wiki/Bristol-Myers_Squibb
http://en.wikipedia.org/wiki/AstraZeneca
http://www.findaumdoc.com/Profile.aspx?id=1103&AE=American%20Board%20of%20Int%20Med-Endocrinology%20Diabetes%20&%20Metaboli&PL=

Read Full Article

Find out if you qualify for discount Diabetic testing supplies, free offers or other running discounts at this time.


  1. First Name*
    Enter first name
  2. Last Name*
    Enter last name
  3. Phone*
    Enter valid US phone number
  4. E-mail*
    Enter email address



By submitting this form I authorize to be contacted by telephone. Please be assured that we value and protect your privacy. Co-Pays and Deductibles may apply.

About The Diabetes Network

The Diabetes Network was developed with the idea that people living with diabetes needed a central place to go for resources as well as get ideas, suggestions and encouragement. We have put a lot of effort into this website to make it easy and fun to navigate as well as informative so that you can have a voice when it comes to managing your diabetes. Please let us know how we can improve this website to better suit your needs.

More about our Mission

We're on a mission to make the healthcare community more technologically advanced than ever before. This website adapts to fit your tablet, iPad®, iPhone®, Android® or other smartphone. Just one of the ways we are working to make life easier for those living with Diabetes. Learn More...